In this section, we focus on pathways regulating β-cell mass that have been shown to be dysregulated in T2DM conditions: PI3K-AKT/PKB pathway, Ras/Raf/Extracellular signal-regulated kinase (ERK) pathway, and cell cycle regulation (Figure 1). Here, AKT1 is linked to type 2 diabetes mellitus.